Do different dialytic techniques have different atherosclerotic and antioxidant activities?

ASAIO Journal

Volumn 47, Issue 5, 2001, Pages 516-521

  Biasioli, Stefano ^a   Schiavon, Renzo ^a   Petrosino, Luigi ^a   Cavallini, Lucia ^a   De Fanti, Emanuela ^a   Zambello, Alberto ^a   Borin, Donata ^a   Targa, Lino ^a  

^a Legnago Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANTS; DIALYSIS; HEMOGLOBIN; PATIENT TREATMENT;

CHRONIC EFFECTS;

BIOMEDICAL ENGINEERING;

BICARBONATE; CATALASE; CYSTEINE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEMOGLOBIN; HOMOCYSTEINE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BIOFILTRATION; CALCULATION; CONTROLLED STUDY; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; TECHNIQUE;

EID: 0034827719     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200109000-00024     Document Type: Article

References (60)

1. Homocysteine and atherothrombosis
2. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease
3. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
4. Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide
5. The oxidant stress of hyperhomocystinemia
6. Hyperhomocystinemia and atherothrombosis
7. Hyperhomocystinemia, a risk factor for atherosclerosis of chronic uremic patients
8. Prospective study of hyperhomocystinemia as an adverse cardiovascular risk factor in end stage renal disease
9. The role of erythrocytes in the deperoxidative processes in people on HD
10. Free radicals and oxidative stress challenge dialysis patients: Effects of two different membranes
11. HPLC method for rapid and accurate determination of homocysteine in plasma and serum
12. An improved coupled test procedure for glutathione peroxidase in blood
13. Methods for determination of lipid peroxidation in biological samples
14. Hyperhomocystinemia and the risk for vascular disease in hemodialysis patients
15. Hyperhomocysteinaemia: A significant risk factor for cardiovascular disease in renal transplant recipients
16. Hyperhomocystinemia as a possible role for atherosclerosis in CAPD patients
17. Homocysteine: A new atherosclerotic risk factor in end stage renal failure
18. The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis padents
19. Lipid peroxidation and antioxidant as biomarkers of tissue damage
20. Serum antioxidant activity in uraemic patients
21. Red blood cell peroxidation in predialysis renal failure
22. Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis
23. Free oxygen species metabolism during haemodialysis with different membranes
24. Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients
25. Trace elements and lipid peroxidation abnormalities in patients with chronic renal failure
26. Increased lipid peroxidation in patients on maintenance haemodialysis
27. Lipid peroxidation in continuous ambulatory dialysis patients
28. Effect of haemodialysis in lipid peroxidation and antioxidant system in patients with chronic renal failure
29. Neutropenia and plasma free radical reaction products during haemodialysis
30. Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular HD
31. Red blood cells and platelet membrane fatty acids in nondialyzed and dialyzed uremics
32. Superoxide anion generation, erythrocytes superoxidedismutase activity and lipid peroxidation during haemoperfusion and haemodialysis in chronic uremic patients
33. Evaluation of RCB lipoperoxidation in HD patients during EPO therapy supplemented or not with iron
34. Platelet lipid peroxidation in haemodialysis patients: Effects of vitamin E supplementation
35. Evidence for oxidative during in vitro dialysis
36. Lipid peroxidation as an indicator of biocompatibility in HD
37. Lipid peroxidation abnormalities in HD patients
38. Reduced erythrocyte: Defense mechanism against free radical toxicity in patients with CRF
39. Erythrocyte defense mechanism against free oxygen radicals in HD children
40. Antioxidant enzymes and lipoperoxide in blood in uremic children and adolescent
41. Serum and erythrocyte: Glutathione reductase activity in chronic renal failure
42. Erythrocyte and plasma glutathione levels in patients with chronic renal insufficiency
43. Glutathione and its associated enzymes in peripheral blood cells in different stages of chronic renal insufficiency
44. Erythrocyte GPx and SOD activities in different stages of CRF
45. Effects of HD on total antioxidant capacity and serum antioxidants in patients with CRF
46. Glutathione peroxidase compensates for the hypersensitivity of cuprophan. Zn superoxide dismutase over producers to oxidant stress
47. Erythrocyte glutathione concentration as a measure of oxidant stress in patients undergoing dapsone therapy
48. Stress eritrocitario nei trattamenti dialitici extracorporei. Livelli enzimatici, stato energetico e redox
49. Lipid abnormalities of erythrocyte membranes in HD patients with CRF
50. Advanced oxidation protein product as a novel marker of oxidative stress in uremia
51. Protein oxidation in HD and kidney transplantation
52. Trace elements and lipid peroxidation in uremic patients on HD
53. No direct evidence of increased lipid peroxidation in HD patients
54. Decreased serum antioxidant activity of HD patients demonstrated by methylguanidine synthesis and microsomal lipid peroxidation
55. Antioxidant and malondialdehyde during HD with CDA and PS membranes
56. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease
57. Dialysis kinetics of homocysteine and ROS
58. Role of cellulosic and non cellulosic membranes on hyperhomocystinemia and oxidative stress
59. Homocysteine as a cardiovascular risk factor